RECALL RECORD — CLASS IIRecall closedF-0919-2018/FDA enforcement
Paige Common·Food·Mar 6, 2018

Maple Minis-gluten Free, Donut Bites

What you need to know

Class II
  • What happened

    Maple Minis are recalled due to undeclared soy lecithin.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. An allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

  • Action required

    Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction.

Recall closed · classified by the FDAINMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand namePaige Common
Recalling firmPaige CommonPortland, OR, United States
UPC / barcodes
8 81314 32681 5
Lot / date codes
  • Sell by 5/6/2018
Distribution area
IN

distributed in Oregon

United States

Quantity affected46 packages
Recall initiationFDA report date: March 21, 2018
FDA recall numberF-0919-2018

Beyond the headline

The recall, in context

Paige Common initiated this food recall on March 6, 2018. The FDA enforcement report states: Maple Minis are recalled due to undeclared soy lecithin. The FDA report lists distribution as: distributed in Oregon.

The FDA enforcement report describes the reason as: Maple Minis are recalled due to undeclared soy lecithin.

Maple Minis-gluten Free, Donut Bites was made or distributed by Paige Common in Portland, OR, United States. This page reflects FDA report F-0919-2018, dated March 21, 2018.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, an allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared wheat or gluten

Symptoms to watch for

Wheat allergy can cause hives, nausea, cramps, breathing difficulty or anaphylaxis. For celiac disease, even small amounts of gluten can cause intestinal damage.

When symptoms may appear

Allergic reactions can begin within minutes to hours. Celiac-related intestinal effects may be delayed.

Higher-risk groups

People with wheat allergy, celiac disease, non-celiac gluten sensitivity or a history of anaphylaxis.

What to do now

  1. 1Do not eat the product if you have a wheat allergy or must avoid gluten.
  2. 2Seek emergency care for breathing difficulty or other signs of a severe allergic reaction.
  3. 3Keep the packaging and contact the retailer or manufacturer about a refund.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Maple Minis-gluten Free, Donut Bites recall?

Paige Common recalled Maple Minis-gluten Free, Donut Bites in an FDA Class II enforcement action reported as F-0919-2018. Maple Minis are recalled due to undeclared soy lecithin.

What are the symptoms of Undeclared wheat or gluten exposure?

Wheat allergy can cause hives, nausea, cramps, breathing difficulty or anaphylaxis. For celiac disease, even small amounts of gluten can cause intestinal damage.

How quickly can Undeclared wheat or gluten symptoms appear?

Allergic reactions can begin within minutes to hours. Celiac-related intestinal effects may be delayed.

Who is most at risk from Undeclared wheat or gluten?

People with wheat allergy, celiac disease, non-celiac gluten sensitivity or a history of anaphylaxis.

What should I do if I bought this product?

Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction. Do not eat the product if you have a wheat allergy or must avoid gluten. Seek emergency care for breathing difficulty or other signs of a severe allergic reaction. Keep the packaging and contact the retailer or manufacturer about a refund.

How do I get a refund from Paige Common?

Contact the recalling company or the retailer where you purchased the product, quote the FDA recall number and ask about a refund or replacement. Keep the packaging, lot code and proof of purchase where possible. The FDA does not issue consumer refunds. Reference FDA recall F-0919-2018 and keep the packaging, lot code and proof of purchase if you have them.

Is the Paige Common recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0919-2018. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Paige Common

View brand

Related alerts

Recent Undeclared allergens recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.